MetaVia Inc. — Director's Dealing 2016

Aug 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2016-08-10

Reporting Person: KOUSKY KENNETH W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-10	Common Stock	C	95439	—	Acquired	95439	Indirect
2016-08-10	Common Stock	J	10439	$6.7059	Acquired	105878	Indirect
2016-08-10	Common Stock	C	116891	$6.7059	Acquired	116891	Indirect
2016-08-10	Common Stock	P	1000	$10.00	Acquired	1000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-10	Series A Convertible Preferred Stock	$	C	95439	Disposed		Common Stock (95439)	Indirect
2016-08-10	8% Convertible Subordinated Promissory Notes	$6.7059	C		Disposed		Common Stock (116891)	Indirect

Footnotes

F1: The Series A Convertible Preferred Stock converted into shares of common stock, par value $0.001 per share (the "Common Stock"), of Gemphire Therapeutics Inc. (the "Company") on a one-for-one basis immediately prior to the closing of the Company's initial public offering and had no expiration date.

F2: Mr. Kousky, as the Manager of BWA Gemphire Investment Group, LLC ("BWA"), beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the securities held by BWA except to the extent of his pecuniary interest therein.

F3: Represents shares of Common Stock issued for payment of accrued dividends on the Series A Convertible Preferred Stock.

F4: Mr. Kousky, as the Manager of BWA Gemphire Investment Group II, LLC ("BWA II"), beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the securities held by BWA II except to the extent of his pecuniary interest therein.

F5: The notes were issued in the original principal amount of $746,500. The outstanding principal and $37,367 of accrued interest on the notes automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering.